📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Protypia

1.1 - Company Overview

Protypia Logo

Protypia

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of high-quality, targeted tissue-based protein and peptide mass spectrometry. Offers a Targeted Proteomics Platform that quantifies drug target systems in various biological samples, integrating protein-level pharmacology and pathology across therapeutic areas, and MS Protein Analysis to identify therapeutic targets and protein features related to drug resistance and response.

Products and services

  • Targeted Proteomics Platform: Architects a targeted platform quantifying drug target systems across diverse biological samples, integrating protein-level pharmacology with pathology across therapeutic areas
  • Tissue-Based Protein and Peptide Mass Spectrometry: Delivers tissue-based, high-quality targeted mass spectrometry of proteins and peptides for precise measurements within tissue samples
  • MS Protein Analysis: Produces mass spectrometry-based identification of therapeutic targets and protein features related to drug resistance and response.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Protypia

Cartana Logo

Cartana

HQ: Sweden Website
  • Description: Provider of in situ sequencing (ISS) technology to map gene expression in brain tissue, enabling simultaneous analysis of hundreds of genes across all cells in a tissue while preserving tissue morphology, with high sensitivity and throughput.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cartana company profile →
Nextcode Logo

Nextcode

HQ: United States Website
  • Description: Provider of sequence-based clinical diagnostics and genome interpretation solutions that address big data challenges, leveraging technology developed over more than 16 years at deCODE genetics to enable the widespread incorporation of genome sequence data into patient diagnosis and care.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nextcode company profile →
Inari Logo

Inari

HQ: United States Website
  • Description: Provider of seed design and biotechnology focused on developing seeds for a nature-positive food system, leveraging predictive design and multiplex gene editing to transform agriculture and its impact on society and the environment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Inari company profile →
NuGEN Logo

NuGEN

HQ: United States Website
  • Description: Provider of innovative genomics sample preparation solutions enabling scientists to access true biology in all samples, independent of type, quality and amount, for analysis on leading analytical platforms, ensuring robust and reproducible results for researchers seeking to predict disease
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NuGEN company profile →
Prime Medicine Logo

Prime Medicine

HQ: United States Website
  • Description: Provider of gene editing technologies and therapies utilizing Prime Editing to modify genetic sequences to treat a wide range of diseases. Offerings include Prime Editors for precise edits across tissues and cell types, Dual Flap Prime Editing for broader edits, PASSIGE for inserting large gene-sized sequences, and Prime-Edited Cell Therapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Prime Medicine company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Protypia

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Protypia

2.2 - Growth funds investing in similar companies to Protypia

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Protypia

4.2 - Public trading comparable groups for Protypia

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Protypia

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Protypia

What does Protypia do?

Protypia is a provider of high-quality, targeted tissue-based protein and peptide mass spectrometry. Offers a Targeted Proteomics Platform that quantifies drug target systems in various biological samples, integrating protein-level pharmacology and pathology across therapeutic areas, and MS Protein Analysis to identify therapeutic targets and protein features related to drug resistance and response.

Who are Protypia's competitors?

Protypia's competitors and similar companies include Cartana, Nextcode, Inari, NuGEN, and Prime Medicine.

Where is Protypia headquartered?

Protypia is headquartered in United States.

How many employees does Protypia have?

Protypia has 1,000 employees 🔒.

When was Protypia founded?

Protypia was founded in 2010 🔒.

What sector and industry vertical is Protypia in?

Protypia is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Protypia

Who are the top strategic acquirers in Protypia's sector and industry

Top strategic M&A buyers and acquirers in Protypia's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Protypia?

Top strategic M&A buyers groups and sectors for Protypia include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Protypia's sector and industry vertical

Which are the top PE firms investing in Protypia's sector and industry vertical?

Top PE firms investing in Protypia's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Protypia's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Protypia's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Protypia's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Protypia include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Protypia's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Protypia?

The key public trading comparables and valuation benchmarks for Protypia include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Protypia for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Protypia with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Protypia's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Protypia with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Protypia's' sector and industry vertical?

Access recent funding rounds and capital raises in Protypia's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Protypia